Invesco Biotechnology & Genome ETF
PBE
PBE
95 hedge funds and large institutions have $105M invested in Invesco Biotechnology & Genome ETF in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 97 → 95 (-2)
Holders
95
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.4M | |
| 2 | +$2.33M | |
| 3 | +$2.17M | |
| 4 |
GKWIM
Gerber Kawasaki Wealth & Investment Management
Santa Monica,
California
|
+$1.64M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.33M |
Top Sellers
| 1 | -$1.14M | |
| 2 | -$524K | |
| 3 | -$510K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$411K |
| 5 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$205K |